AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $399,000 | +358.6% | 142,482 | +312.8% | 0.00% | – |
| Q3 2020 | $87,000 | -71.3% | 34,512 | +54.6% | 0.00% | – |
| Q2 2020 | $303,000 | -48.7% | 22,328 | -71.4% | 0.00% | -100.0% |
| Q1 2020 | $591,000 | -60.0% | 77,961 | -56.8% | 0.00% | 0.0% |
| Q1 2019 | $1,478,000 | -57.0% | 180,482 | -47.6% | 0.00% | -66.7% |
| Q2 2018 | $3,438,000 | -28.0% | 344,447 | -31.2% | 0.00% | -40.0% |
| Q1 2018 | $4,774,000 | -9.1% | 500,971 | +41.9% | 0.01% | 0.0% |
| Q4 2017 | $5,251,000 | +23.8% | 353,111 | +63.8% | 0.01% | +25.0% |
| Q3 2017 | $4,240,000 | +218.6% | 215,544 | +132.7% | 0.00% | +300.0% |
| Q2 2017 | $1,331,000 | – | 92,620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |